Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
190 participants
OBSERVATIONAL
2023-12-30
2025-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss in Placenta Accreta
NCT06351969
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
NCT03416296
Accuracy of Placenta Accreta Index in Diagnosing Placenta Accreta Spectrum
NCT04314791
Diagnostic Accuracy of Placental Thickness in Lower Uterine Segment Measured By Ultrasound in Prediction of Placenta Accreta Spectrum in Patients With Placenta Previa. A Diagnostic Test Accuracy Study
NCT05500404
Ultrasound in Prediction of Operative Findings in Cesarean Section Among Placenta Accreta Cases
NCT03286998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
paracervical pouch is defined ultrasonographic as the downward displacement of the uterine serosa from the level of the cervical internal os
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
positive paracervical pouch
The first group will include patients in whom a paracervical pouch is detected by transvaginal ultrasound.
No interventions assigned to this group
negative paracervical pouch
the second group will include patients in whom the pouch is not detected by transvaginal ultrasound
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients had at least one cesarean section.
Exclusion Criteria
* Patients diagnosed with hepatitis B, C, or HIV,
* Those with bleeding diathesis.
* Patients whose BMI is more than 40 kg/m2.
* Patients who need an emergency cesarean section.
19 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar elshorbagy
lecturer in obstetrics and gynecology, faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shih JC, Kang J, Tsai SJ, Lee JK, Liu KL, Huang KY. The "rail sign": an ultrasound finding in placenta accreta spectrum indicating deep villous invasion and adverse outcomes. Am J Obstet Gynecol. 2021 Sep;225(3):292.e1-292.e17. doi: 10.1016/j.ajog.2021.03.018. Epub 2021 Mar 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
26/564
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.